Biopharmaceutical manufacturers are beginning to adopt the tools and techniques already used in other high-value sectors, such as semiconductors and electronics, to increase process capability and reliability. Increasingly, digital models are employed to predict quality, identify abnormalities and control the process more effectively.
Model development is constantly evolving, as new data becomes available. It is vital to exploit these models for more than just real time release. Their management - as well as their development - should focus on deriving maximum process knowledge, to help drive process improvement.
To support this next phase of manufacturing intelligence, Perceptive Engineering has released
BioAPC®, a purpose-built platform for biopharma.
BioAPC from Perceptive Engineering
Supports batch and continuous processes
Flexible design and real-time execution of Design of Experiments studies with integrated sample management.
Offline data analysis, pre-treatment and visualisation using BioAPC® Development
Model Development and Maintenance facilities in-built
Real Time MVA Quality monitoring, Control and Predictive Maintenance
Throughout development to manufacturing, data is key to enable rapid response to market demand. The knowledge to enable intelligent decisions and the wisdom to optimise the complete product lifecycle is now at your fingertips. The latest release of PerceptiveAPC v8.0 delivers the next
PD2M May 18-20 2021 Virtual This is the place to explore what pharmaceutical manufacturing will look like in 2030, sharing discussions on new ways to develop medicines. How will Industry 4.0 enable us to respond to market demand, delivering flexible, modular manufacturing and bringing
18-19 May 2021 Virtual Perceptive Engineering - an Applied Materials company - is looking forward to participating in the Bionow Pharma Manufacturing Conference 2021. We will be joining AstraZeneca and Bristol Meyers Squibb in session 2, discussing the ‘Digitisation of Pharma